Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
Sign Up to like & getrecommendations! Published in 2017 at "Blood Cancer Journal"
DOI: 10.1038/bcj.2017.46
Abstract: Little is known about the impact of multiple myeloma (MM) treatment on uninvolved immunoglobulins (Ig). We identified 448 patients who received high-dose dexamethasone (HD-DEX), lenalidomide and dexamethasone (RD), bortezomib and dexamethasone (VD), bortezomib, cyclophosphamide and… read more here.
Keywords: newly diagnosed; multiple myeloma; uninvolved immunoglobulins; therapy ... See more keywords
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia"
DOI: 10.1038/leu.2016.140
Abstract: Immunoparesis is an adverse prognostic marker in plasma cell proliferative disorders. Its impact in AL amyloidosis has not been explored in depth. Newly diagnosed AL amyloidosis patients (n=998) were evaluated for immunoparesis by two methods.… read more here.
Keywords: newly diagnosed; response; diagnosed amyloidosis; amyloidosis ... See more keywords